Exparel and Education to Avoid Opioids After Carpal Tunnel Release

Description

This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.

Conditions

Carpal Tunnel Syndrome

Study Overview

Study Details

Study overview

This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

Condition
Carpal Tunnel Syndrome
Intervention / Treatment

-

Contacts and Locations

Dayton

Orthopedic Associates of Southwest Ohio, Dayton, Ohio, United States, 45414

Dayton

Orthopedic Associates of Southwest Ohio, Dayton, Ohio, United States, 45459

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * carpal tunnel syndrome diagnosed either by physical exam or EMG
  • * age \>18.
  • * allergy to bupivacaine
  • * pre-operative opioid usage within the last six months
  • * patients allergic to Percocet or acetaminophen
  • * patients taking tricyclic antidepressants (interaction with bupivacaine)
  • * vulnerable populations (prisoners or pregnant women)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Kettering Health Network,

Ronald Buczek, DO, PRINCIPAL_INVESTIGATOR, Kettering Health Network

Study Record Dates

2025-03-31